Advertisement

Central Neurocytoma

  • Shireen Parsai
  • Senthilkumar Gandhidasan
  • John H. Suh
Chapter

Abstract

Central neurocytoma is a rare brain tumor usually in young adults, which arises most commonly in the supratentorial ventricular system. It frequently causes obstructive hydrocephalus and symptoms of increased intracranial pressure. Diagnosis is made based on characteristic pathologic findings consistent with neuronal differentiation including immunoreactivity with antibody to synaptophysin. Treatment paradigms include maximal safe surgical resection or definitive radiotherapy. After surgical resection, adjuvant radiotherapy may be indicated in the event of subtotal resection or if adverse pathologic features such as elevated MIB-1 labeling index are identified. In general, radiation therapy may be prescribed as conventionally fractionated radiotherapy to doses of 45–54 Gy at 1.8–2.0 Gy/fx for benign neurocytomas or 54–60 Gy in 2.0 Gy/fx for atypical neurocytomas. Stereotactic radiosurgery experiences have used mean marginal doses ranging from 10.5 to 20 Gy, though the majority were treated with mean marginal doses of 14–18 Gy in a single fraction. Local control is favorable with these therapies. After completion of radiotherapy, patients should be followed in the long term to evaluate for potential recurrences and radiation-induced late toxicities.

Keywords

Central neurocytoma Intraventricular Septum pellucidum Atypical Radiation therapy 

References

  1. 1.
    Hassoun J, Gambarelli D, Grisoli F, et al. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol. 1982;56(2):151–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Kim DG, Park CK. Central neurocytoma: establishment of the disease entity. Neurosurg Clin N Am. 2015;26(1):1–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Schmidt MH, Gottfried ON, von Koch CS, et al. Central neurocytoma: a review. J Neurooncol. 2004;66(3):377–84.PubMedCrossRefGoogle Scholar
  4. 4.
    Patel DM, Schmidt RF, Liu JK. Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma. J Clin Neurosci. 2013;20(9):1193–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Yang I, Ung N, Chung LK, et al. Clinical manifestations of central neurocytoma. Neurosurg Clin N Am. 2015;26(1):5–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Wong J, Teo C, Kwok B. Central neurocytoma in third and fourth ventricles with aqueductal involvement. Br J Neurosurg. 2006;20(1):57–62.PubMedCrossRefGoogle Scholar
  7. 7.
    Donoho D, Zada G. Imaging of central neurocytomas. Neurosurg Clin N Am. 2015;26(1):11–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Choudhari KA, Kaliaperumal C, Jain A, et al. Central neurocytoma: a multi-disciplinary review. Br J Neurosurg. 2009;23(6):585–95.PubMedCrossRefGoogle Scholar
  9. 9.
    Paek SH, Kim JE, Kim DG, et al. Angiographic characteristics of central neurocytoma suggest the origin of tumor. J Korean Med Sci. 2003;18(4):573–80.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Rades D, Schild SE, Fehlauer F. Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology. 2004;62(6):987–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.PubMedCrossRefGoogle Scholar
  13. 13.
    Soylemezoglu F, Scheithauer BW, Esteve J, et al. Atypical central neurocytoma. J Neuropathol Exp Neurol. 1997;56(5):551–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Sgouros S, Carey M, Aluwihare N, et al. Central neurocytoma: a correlative clinicopathologic and radiologic analysis. Surg Neurol. 1998;49(2):197–204.PubMedCrossRefGoogle Scholar
  15. 15.
    Cobery ST, Noren G, Friehs GM, et al. Gamma knife surgery for treatment of central neurocytomas. Report of four cases. J Neurosurg. 2001;94(2):327–30.PubMedCrossRefGoogle Scholar
  16. 16.
    Qian H, Lin S, Zhang M, et al. Surgical management of intraventricular central neurocytoma: 92 cases. Acta Neurochir. 2012;154(11):1951–60.PubMedCrossRefGoogle Scholar
  17. 17.
    Imber BS, Braunstein SE, Wu FY, et al. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol. 2016;126(1):193–200.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Rades D, Fehlauer F. Treatment options for central neurocytoma. Neurology. 2002;59(8):1268–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Rades D, Fehlauer F, Schild SE. Treatment of atypical neurocytomas. Cancer. 2004;100(4):814–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Rades D, Fehlauer F, Lamszus K, et al. Well-differentiated neurocytoma: what is the best available treatment? Neuro Oncol. 2005;7(1):77–83.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Rades D, Schild SE. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Cancer. 2006;106(5):1140–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Kim DG, Paek SH, Kim IH, et al. Central neurocytoma: the role of radiation therapy and long term outcome. Cancer. 1997;79(10):1995–2002.PubMedCrossRefGoogle Scholar
  23. 23.
    Park HK, Steven DC. Stereotactic radiosurgery for central neurocytoma: a quantitative systematic review. J Neurooncol. 2012;108(1):115–21.PubMedCrossRefGoogle Scholar
  24. 24.
    Rades D, Fehlauer F, Ikezaki K, et al. Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas. Radiother Oncol. 2005;74(1):67–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Louis DN, Swearingen B, Linggood RM, et al. Central nervous system neurocytoma and neuroblastoma in adults—report of eight cases. J Neurooncol. 1990;9(3):231–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Fujimaki T, Matsuno A, Sasaki T, et al. Proliferative activity of central neurocytoma: measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index. J Neurooncol. 1997;32(2):103–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Sharma MC, Sarkar C, Karak AK, et al. Intraventricular neurocytoma: a clinicopathological study of 20 cases with review of the literature. J Clin Neurosci. 1999;6(4):319–23.PubMedCrossRefGoogle Scholar
  28. 28.
    Ashkan K, Casey AT, D’Arrigo C, et al. Benign central neurocytoma. Cancer. 2000;89(5):1111–20.PubMedCrossRefGoogle Scholar
  29. 29.
    Lenzi J, Salvati M, Raco A, et al. Central neurocytoma: a novel appraisal of a polymorphic pathology. Our experience and a review of the literature. Neurosurg Rev. 2006;29(4):286–92. discussion 292PubMedCrossRefGoogle Scholar
  30. 30.
    Leenstra JL, Rodriguez FJ, Frechette CM, et al. Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys. 2007;67(4):1145–54.PubMedCrossRefGoogle Scholar
  31. 31.
    Paek SH, Han JH, Kim JW, et al. Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol. 2008;90(1):25–30.PubMedCrossRefGoogle Scholar
  32. 32.
    Chen CM, Chen KH, Jung SM, et al. Central neurocytoma: 9 case series and review. Surg Neurol. 2008;70(2):204–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Pollock BE, Stafford SL. Stereotactic radiosurgery for recurrent central neurocytoma: case report. Neurosurgery. 2001;48(2):441–3.PubMedGoogle Scholar
  34. 34.
    Bertalanffy A, Roessler K, Dietrich W, et al. Gamma knife radiosurgery of recurrent central neurocytomas: a preliminary report. J Neurol Neurosurg Psychiatry. 2001;70(4):489–93.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Anderson RC, Elder JB, Parsa AT, et al. Radiosurgery for the treatment of recurrent central neurocytomas. Neurosurgery. 2001;48(6):1231–7. discussion 1237–8PubMedGoogle Scholar
  36. 36.
    Martin JM, Katati M, Lopez E, et al. Linear accelerator radiosurgery in treatment of central neurocytomas. Acta Neurochir. 2003;145(9):749–54. discussion 754PubMedCrossRefGoogle Scholar
  37. 37.
    Hara M, Aoyagi M, Yamamoto M, et al. Rapid shrinkage of remnant central neurocytoma after gamma knife radiosurgery: a case report. J Neurooncol. 2003;62(3):269–73.PubMedCrossRefGoogle Scholar
  38. 38.
    Kim CY, Paek SH, Jeong SS, et al. Gamma knife radiosurgery for central neurocytoma: primary and secondary treatment. Cancer. 2007;110(10):2276–84.PubMedCrossRefGoogle Scholar
  39. 39.
    Yen CP, Sheehan J, Patterson G, et al. Gamma knife surgery for neurocytoma. J Neurosurg. 2007;107(1):7–12.PubMedCrossRefGoogle Scholar
  40. 40.
    Matsunaga S, Shuto T, Suenaga J, et al. Gamma knife radiosurgery for central neurocytomas. Neurol Med Chir. 2010;50(2):107–12. disucussion 112–3CrossRefGoogle Scholar
  41. 41.
    Genc A, Bozkurt SU, Karabagli P, et al. Gamma knife radiosurgery for cranial neurocytomas. J Neurooncol. 2011;105(3):647–57.PubMedCrossRefGoogle Scholar
  42. 42.
    Karlsson B, Guo WY, Kejia T, et al. Gamma knife surgery for central neurocytomas. J Neurosurg. 2012;117(Suppl):96–101.PubMedGoogle Scholar
  43. 43.
    Monaco EA 3rd, Niranjan A, Lunsford LD. The management of central neurocytoma: radiosurgery. Neurosurg Clin N Am. 2015;26(1):37–44.PubMedCrossRefGoogle Scholar
  44. 44.
    Yamanaka K, Iwai Y, Shuto T, et al. Treatment results of gamma knife radiosurgery for central neurocytoma: report of a Japanese multi-institutional cooperative study. World Neurosurg. 2016;90:300–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Lawrence YR, Li XA, el Naqa I, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S20–7.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Douw L, Klein M, Fagel SS, et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol. 2009;8(9):810–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Barani IJ, Raleigh DR, Larson D. The management of central neurocytoma: radiotherapy. Neurosurg Clin N Am. 2015;26(1):45–56.PubMedCrossRefGoogle Scholar
  48. 48.
    Kim JW, Kim DG, Kim IK, et al. Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years’ experience in a single institute. Neurosurgery. 2013;72(3):407–13. discussion 413–4PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Shireen Parsai
    • 1
  • Senthilkumar Gandhidasan
    • 2
  • John H. Suh
    • 1
  1. 1.Department of Radiation Oncology, Taussig Cancer InstituteCleveland ClinicClevelandUSA
  2. 2.Department of Radiation OncologyIllawarra Cancer Care CentreWollongongAustralia

Personalised recommendations